首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Bioorganic & medicinal chemistry

缩写:BIOORGAN MED CHEM

ISSN:0968-0896

e-ISSN:1464-3391

IF/分区:3.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11373
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Masaya Denda,Yutaka Kohmura,Daishiro Kobayashi et al. Masaya Denda et al.
Protein-protein interactions (PPIs) are attractive yet challenging drug targets, motivating the development of conformationally constrained peptides such as stapled α-helices. Here we report a one-pot cysteine-tryptophan (Cys-Trp) cross-li...
Sumit Gangopadhyay,Swrajit Nath Sharma,Gourav Das et al. Sumit Gangopadhyay et al.
Various lipid-based siRNA drug delivery strategies are being developed for efficient delivery to extrahepatic organs. In this report, we studied the synergistic effect of 4'-O-hexadecyl-2'-dT and terminal phosphorothioate modifications on s...
Sumit Kumar,Renata Pessôa Germano Mendes,Meenakshi Bansal et al. Sumit Kumar et al.
SARS-CoV-2 has caused a global epidemic, causing grave public health concerns. In this work, we synthesized a library of 28 compounds derived from the fusion of hydroxyethylamine and aniline and evaluated their antiviral activity. During th...
Sebastian Flieger,Emma H Kelley,Thahani S Habeeb Mohammad et al. Sebastian Flieger et al.
A series of N-aryl sulfonamides was designed, synthesized, and evaluated for their ability to inhibit the bacterial enzyme N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE, EC 3.5.1.18). Our initial lead compound, N-(o-methoxyphenyl)-...
Weiyi Yin,Rui Zhou,Wencui Zhang et al. Weiyi Yin et al.
Viral entry step involves of complex host-virus interactions. Research progress of viral entry inhibitors lags significantly behind that of viral replication inhibitors targeting viral non-structural proteins. Here we take Zika virus (ZIKV)...
Natalie Fuchs,Farida El Gaamouch,Hossam Nada et al. Natalie Fuchs et al.
Fragment-based drug discovery (FBDD) remains a powerful tool in drug development for targeting a wide range of proteins and identifying new small molecule-based scaffolds. Here, we explored a fragment library of 3200 compounds using a tempe...
Adrián Fernández-de-la-Pradilla,Clara Quílez,Tadej Uršič et al. Adrián Fernández-de-la-Pradilla et al.
Cysteine protease cathepsin L (CatL) is linked to cancer, infection, and neurodegeneration, rendering it a compelling target for therapy. Expanding upon dipeptidyl enoates (keto vinyl esters, KVE), we introduce dipeptidyl keto vinyl amides ...
Wen Li,Ruixue Cheng,Yingjie Chang et al. Wen Li et al.
The pursuit of isoform-selective histone deacetylase (HDAC) inhibitors is a promising strategy to overcome the adverse effects associated with pan-HDAC inhibitors. Through systematic structural modification of the known inhibitor PCI-34051,...
Saad Shaaban,Samia S Hawas,Ayman Abo Elmaaty et al. Saad Shaaban et al.
A novel series of methyl selanyl- and 2,4-thiazolidinedione-based hybrids (HB68-HB167) was rationally designed using a fragment-merging strategy, in which key pharmacophoric elements were combined to generate structurally integrated hybrid ...
Tharcisse Gatera,Yi-Dan Zheng,Jia-Rong Liu et al. Tharcisse Gatera et al.
Pancreatic cancer is a highly lethal malignancy with an urgent need for novel therapeutic strategies. Triterpenoids represent key scaffolds, with compelling anticancer potential, yet further structural optimization is required to enhance th...